Researcher.Life Logo

Therapeutic Advances in Drug Safety : Impact Factor & More

eISSN: 2042-0994pISSN: 2042-0986
JournalOpen Access

Key Metrics

CiteScore
6.3
H-Index
42
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Drug Safety

Therapeutic Advances in Drug Safety Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2200
Publication Time9
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Drug Safety ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Drug Safety

Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
  • 3 Apr 2026
  • Therapeutic Advances in Drug Safety
Incidence, risk factors, and prediction model of piperacillin/tazobactam-associated hypokalemia in neonates.
  • 1 Apr 2026
  • Therapeutic advances in drug safety
Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling
  • 31 Mar 2026
  • Therapeutic Advances in Drug Safety
Monitoring of QTc in subjects hospitalized for 1 year in an acute psychiatric ward treated with clotiapine and other associated antipsychotics: a retrospective study
  • 31 Mar 2026
  • Therapeutic Advances in Drug Safety
Treating hearts and minds: adverse cardiovascular effects of psychiatric medications
  • 1 Mar 2026
  • Therapeutic Advances in Drug Safety
Machine learning studies of drug-induced nephrotoxicity: a scoping review
  • 1 Mar 2026
  • Therapeutic Advances in Drug Safety
Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
  • 3 Apr 2026
  • Therapeutic Advances in Drug Safety
Incidence, risk factors, and prediction model of piperacillin/tazobactam-associated hypokalemia in neonates.
  • 1 Apr 2026
  • Therapeutic advances in drug safety
Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling
  • 31 Mar 2026
  • Therapeutic Advances in Drug Safety
Monitoring of QTc in subjects hospitalized for 1 year in an acute psychiatric ward treated with clotiapine and other associated antipsychotics: a retrospective study
  • 31 Mar 2026
  • Therapeutic Advances in Drug Safety
Treating hearts and minds: adverse cardiovascular effects of psychiatric medications
  • 1 Mar 2026
  • Therapeutic Advances in Drug Safety
Machine learning studies of drug-induced nephrotoxicity: a scoping review
  • 1 Mar 2026
  • Therapeutic Advances in Drug Safety

FAQs on Therapeutic Advances in Drug Safety